Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.6K Buy
523
+141
+37% +$15.2K ﹤0.01% 2123
2026
Q1
$39.1K Buy
382
+47
+14% +$4.79K ﹤0.01% 2346
2025
Q4
$33.7K Buy
335
+108
+48% +$10.6K ﹤0.01% 2317
2025
Q3
$19.6K Buy
227
+33
+17% +$2.61K ﹤0.01% 2525
2025
Q2
$14.8K Buy
194
+53
+38% +$3.88K ﹤0.01% 2615
2025
Q1
$10K Sell
141
-36
-20% -$2.81K ﹤0.01% 2744
2024
Q4
$13.9K Sell
177
-11
-6% -$1.03K ﹤0.01% 2453
2024
Q3
$19.2K Buy
188
+93
+98% +$7.71K ﹤0.01% 2131
2024
Q2
$7.21K Sell
95
-2
-2% -$142 ﹤0.01% 2408
2024
Q1
$7.28K Buy
97
+26
+37% +$2.07K ﹤0.01% 2222
2023
Q4
$5.34K Buy
+71
New +$4.39K ﹤0.01% 2211

Other funds holding NUVL

GAMMA Investing's NUVL Position: Q2 2026 in Review

GAMMA Investing increased its Nuvalent (NUVL) stake by 37% in Q2 2026, buying an estimated $15.2K and bringing the position to 523 shares worth $64.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

GAMMA Investing first reported a position in NUVL in Q4 2023 and has held it in 11 quarters since. 14 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • GAMMA Investing held 523 shares of Nuvalent worth $64.6K as of Q2 2026.
  • GAMMA Investing bought 141 Nuvalent shares in Q2 2026, an estimated $15.2K.
  • Nuvalent made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2123 holding.
  • GAMMA Investing first reported a position in Nuvalent in Q4 2023 and has held it in 11 quarters since.
  • 14 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.